2026
|
January 20, 2026
Eric Smith, MD, PhD Dana-Farber Cancer Inst. | Boston, MA CAR T cell therapies: Addressing challenges for the next wave View Presentation Here March 3, 2026
Paul Blainey, PhD Broad Institute of MIT | Cambridge, MA Beyond synthetic lethality and destructive single-cell readouts: new genomic tools for high-content cellular analysis View Presentation Here March 10, 2026
Janis M. Taube, MD Johns Hopkins University | Baltimore, MD Next-Generation Biomarkers for Immunotherapy: Astronomy accelerates Pathology View Presentation Here March 24, 2026
2026 Jean & Jerome Pearlstein Lecture Raul Mostoslavsky, MD, PhD MGH Cancer Center | Boston, MA Linking Metabolism and Epigenetics in Cancer, one gene at a time View Presentation Here March 31, 2026
Andrew White, PhD Future House/Edison Scientific | San Francisco, CA Automating scientific discovery at scale View Presentation Here April 7, 2026
2026 Frederick P. Li Lecture Christian P. Kratz, MD Hannover Medical School | Hannover, Germany Old dog new tricks – KRAS, TP53, and BRCA2 View Presentation Here May 5, 2026
2026 Louise & Herbert Shivek Lecture David T.W. Jones, PhD Hopp Children's Cancer Ctr. | Germany Molecular-clinical correlations and novel model systems for pediatric low-grade glioma View Presentation Here May 12, 2026
2026 Clinical Lecture in Oncology Qing Zhang, PhD UT Southwestern Medical Ctr. | Dallas, TX Truncal Vulnerability in ccRCC View Presentation Here May 19, 2026
2026 Krakoff Family Lecture Anirban Maitra, MBBS NYU Langone Health | New York Mediators of Restraint in Early Pancreatic Neoplasia View Presentation Here June 16, 2026
2026 Emily Frederick DiMaggio Lecture Irene Ghobrial, MD Dana-Farber Cancer Inst. | Boston, MA Early Detection and Interception of Multiple Myeloma View Presentation Here June 23, 2026
2026 Susan Swerling Lectures John Anderson, MD, PhD Univ. of College London | London Engineering drug sensitive CAR-T cells for pediatric solid cancer combination therapies Mirit Aladjem, PhD National Institute of Health | Bethesda, MD DNA Damage Signaling at Replication Origins Reveals Therapeutic Vulnerabilities in Cancer View Presentation Here |
